Bringing the fundamentals into focus…
Back to Indivior Pharmaceuticals, Inc.
How Indivior Pharmaceuticals, Inc. stacks up
INDV · against 231 other Healthcare companies of similar size
Growth
88/ 100
Near the top of its peers.
Ranked #35 of 232 · scores higher than 85% of peers
Bars: peers in each 10-point band of the growth score28 peers with a growth score of 80–89, including INDV · Click a bar to see the companies
Why growth scores 88?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth, revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- faster revenue growth over three years: stronger than 65% of peers. 3-year revenue growth: 11.2% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 69% of peers. Revenue growth: 13.5% vs peer median 6.1%
- faster growth in earnings per share: stronger than 94% of peers. Earnings per share growth: 248.5% vs peer median 9.8%
Metric by metric
Position: dot = INDV, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | INDV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 231 reported | 13.5% | 7.7% | 63% | 33% | |
| Earnings per share growthHigher is better · 147 reported | 248.5% | 12.3% | 93% | 33% | |
| 3-year revenue growthHigher is better · 226 reported | 11.2% | 8.6% | 59% | 33% |
Ranking by growth score
Top 5 and the companies ranked around INDV| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 5 | 19.7B HKD (≈$2.5B) | 98 | 84 | |
| 31 | 18.7B CNY (≈$2.6B) | 89 | 51 | |
| 31 | 2.4B EUR (≈$2.6B) | 89 | 69 | |
| 31 | 7.0B USD | 89 | 57 | |
| 31 | 2.2B USD | 89 | 32 | |
| 35 | 4.3B USD | 88 | 69 | |
| 35 | 4.6B USD | 88 | 61 | |
| 37 | 182.3B INR (≈$2.2B) | 87 | 66 | |
| 38 | 936.1B JPY (≈$6.4B) | 86 | 80 | |
| 38 | 2.3B USD | 86 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score